Abstract
THE treatment of cholera by intravenous fluids and electrolytes is well established and, if instituted before dehydration and shock are irreversible, can completely protect the patient. But in times of large-scale outbreaks neither the personnel nor material (approximately 10–20 l. per patient) is usually available1. Trials of oral fluid and electrolyte replacement therapy have been effective because the absorption of salts, water and carbohydrates are unimpaired by such treatment2–4. This greatly simplifies treatment, but again limitation in the availability of materials and personnel may not allow treatment of all victims during severe epidemics. Since both these methods do not treat the severe diarrhoea but only attempt to replace fluid and electrolyte losses throughout the period (3–5 days) of diarrhoea, the patient is still debilitated and unable to carry on normal activities. A drug which could be given orally to reverse the massive loss of fluid and electrolytes by antagonizing the effect of cholera enterotoxin on secretory mechanisms of the small intestine has been suggested as a rational means to attack cholera with the least number of trained people and equipment5–7.
Similar content being viewed by others
References
Phillips, R. A., Ann. Intern. Med., 65, 922 (1960).
Hirschhorn, N., Kinzie, J. L., Sachar, D. B., Northrup, R. S., Taylor, J. O., Ahmad, S. Z., and Phillips, R. A., New Engl. J. Med., 279, 176 (1968).
Nalin, D. R., Cash, R. A., Rahman, M., Yunus, M. D., Gut, 11, 768 (1970).
Sack, R. B., Cassells, J., Mitra, R., Merritt, C., Butler, T., Thomas, J., Jacobs, B., Chadhuri, A., Mondal, A., Bull. World Health Org., 43, 351 (1970).
Feeley, J. C., Texas Rep. Biol. Med., 7, 177 (1969).
Finkelstein, R. A., Jehl, J. J., and Goth, A., Proc. Soc. Exp. Biol. Med., 132, 835 (1969).
Lexomboon, V., Goth, H., and Finkelstein, R. A., Res. Commun. in Chem. Pathol. Pharmacol., 2, 245 (1971).
Sack, R. B., Carpenter, C. C. J., Steenburg, R. W., Pierce, N. F., Lancet, ii, 200 (1966).
Swallow, J. H., Code, C. F., and Freter, R., Gastroenterology, 57, 35 (1968).
Carpenter, C. C. J., Sack, R. B., Feeley, J. C., Steenburg, R. W., J. Clin. Invest., 47, 1210 (1968).
Finkelstein, R. A., Norris, H. T., Dutta, N. K., J. Infect. Dis., 114, 203 (1964).
Aziz, K. M. S., Mohsin, A. K. M., Hare, W. K., Phillips, R. A., Nature, 220, 814 (1968).
Finkelstein, R. A., et al., J. Immunol., 196, 440 (1966).
Awqati, Q. Al, Greenough, W. B., Carpenter, C. C. J., Clin. Res., 17, 422 (1969); Carpenter, C. C. J., Curlin, C. T., Greenough, W. B., J. Infect. Dis., 120, 332 (1969).
Winter, C. A., Nuss, G. W., Arthritis Rheum., 9, 394 (1966).
Carpenter, C. C. J., Amer. J. Med., 50, 1 (1971).
Greenough, W. B., Pierce, N. F., Awqati, Q. Al., Carpenter, C. C. J., J. Clin. Invest., 48, 32a (1969).
Vane, J. R., Nature New Biol., 231, 232 (1971).
Ferreira, S. H., Moncada, S., and Vane, J. R., Nature New Biology, 231, 237 (1971).
Bennett, A., Nature, 231, 536 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
JACOBY, H., MARSHALL, C. Antagonism of Cholera Enterotoxin by Anti-inflammatory Agents in the Rat. Nature 235, 163–165 (1972). https://doi.org/10.1038/235163a0
Received:
Issue Date:
DOI: https://doi.org/10.1038/235163a0
- Springer Nature Limited
This article is cited by
-
Control of Mooij correlations at the nanoscale in the disordered metallic Ta–nanoisland FeNi multilayers
Scientific Reports (2020)
-
The origin of Mooij correlations in disordered metals
npj Quantum Materials (2018)
-
Inverse polymerase chain reaction
Molecular Biotechnology (1994)
-
Effects of acetylsalicylic acid on electromechanical activity ofin vivo rabbit ileum
Digestive Diseases and Sciences (1988)
-
Antidiarrheal therapy
Digestive Diseases and Sciences (1987)